As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is being used in Italy.
Guests:
Tom Whipple, The Times science editor
Someit Sidhu, CEO and Co-founder of Izana Bioscience
**Host: **Manveen Rana
Hosted on Acast. See acast.com/privacy) for more information.
